Therapeutic Solutions International Reports QuadraMune™ Increases T Cell Immunity in Animal Studies

OCEANSIDE, Calif., Dec. 30, 2020 /PRNewswire/ --Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating a two-week course of QuadraMune increased immunological parameters relevant to antiviral immunity.